CYP24A1 and breast cancer: Knockdown of CYP24A1 using shRNA in mammary tumour lines resulted in the suppression of the metabolism of vitamin D and abrogated tumour growth in vivo, supporting the hypothesis that deficiency of vitamin D could be related to breast cancer incidence [109].